Skip to main content
. 2021 Dec 19;12(2):12274–12293. doi: 10.1080/21655979.2021.2006966

Figure 11.

Figure 11.

(a). Cell viability after OGD with different doses of luteolin determined by CCK8. (b). Effects of luteolin on the mRNA levels of MMP9, MAPK3, PTGS2, JUN, IL1B and TNF of PC12 cells. *P < 0.05,**P < 0.01,***P < 0.001 vs. the control group. (c). The expression of MMP9, MAPK3, PTGS2, JUN, IL1B and TNF were examined by Western blotting. (d). Effects of luteolin on the expression levels of MMP9, MAPK3, PTGS2, JUN, IL1B and TNF of PC12 cells. *P < 0.05,**P < 0.01,***P < 0.001 vs. the control group